Giuseppe Danilo Norata
@DaniloNorata
Followers
328
Following
373
Media
21
Statuses
561
Professor of Pharmacology at the University of Milan
Milano
Joined October 2010
A terrific EAS Advanced Course on Non-Classical Risk Factor. I would like to sincerely thank the @society_eas for the opportunity to organize this event and for their continuous commitment in education. The meeting have been truly inspiring. Thanks to all friends a and colleagues
0
6
7
Very looking forward to welcome all the participants in Milan on Oct 30 for the EAS Advanced Course on non‑classical risk factors 🇮🇹meeting with leading experts on atherosclerosis and beyond @cj_binder @society_eas @LabNorata @AndreaBaragetti @Charis_Oxford @fabri_bon87
Join us in Milan on October 30, for the EAS Advanced Course on non-classical risk factors. Held at the Hilton Milano 🇮🇹, this full-day event brings together leading experts to explore emerging topics in cardiovascular science - including MASLD, cardio-renal syndrome,
0
3
7
🎓 PhD Graduation – Università degli Studi di Milano 🎓 Honored of our PhD graduates. Congratulations to all our new PhDs — the future of science is in great hands! 🌟@DaniloNorata
linkedin.com
🎓 PhD Graduation – Università degli Studi di Milano 🎓 Honored to celebrate our PhD graduates alongside Marina Brambilla, Rector of UNIMI. As Coordinator of the PhD course in Pharmacological and...
0
1
5
🧬 Thrilled to share our new publication in Molecular Metabolism! Our findings reveal a role of mitochondrial fusion in promoting lipid imbalance and vascular disease, suggesting that mitochondrial dynamics could be a novel therapeutic target in #CVD
1
4
5
0
1
8
#InterviewsCNIC 🎙️ @DaniloNorata: ‘No #cholesterol, no party’. 🗣️ @DaniloNorata is a Full Professor of #Pharmacology at the Department of Excellence of Pharmacological and Biomolecular Sciences of @LaStatale 🔬💊 His research focuses on the molecular mechanisms involved in
1
3
11
✌️Extra-hepatic effects of anti-pcsk9 options emerging from trials! 😎lowering LDLc as much as possible is 💯safe! proposing position for investors and developers of the novel formulations! Glad to share with @lore_ddlt @DaniloNorata @LabNorata
tandfonline.com
PCSK9 has been widely studied as a target for lipid-lowering as its inhibition increases LDLR recycling on the surface of hepatocytes, which promotes the catabolism of LDL particles. PCSK9 can be s...
0
2
5
🚀 New Review Alert! 🚀 Targeting PCSK9 beyond the liver. PCSK9 is well known for its role in cholesterol metabolism, but emerging evidence suggests its impact extends beyond the liver. @DaniloNorata @AndreaBaragetti
linkedin.com
🚀 New Review Alert! 🚀 Excited to share our latest publication: “Targeting PCSK9 beyond the liver: evidence from experimental and clinical studies” in Expert Opinion on Therapeutics Targets. 💡...
0
2
8
We are excited to share our latest research highlighting how neuronal PCSK9 influences synaptic ApoER2 localization, offering new insights into its role in the brain. https://t.co/lsHjbW01Ar
@DaniloNorata @lore_ddlt
0
3
12
Save the date! 🔔#CNICseminars 🗣️ @DaniloNorata from @LaStatale. ➡️ “#Cholesterol and lipid metabolism as immunometabolic checkpoint in the adaptive immune response”. 🔬🫀 👨🔬 Chair: @SanchoLab 📅 February 24, 12 pm 📍 CNIC Auditorium #SOMMa #CardiovascularResearch #Immunology
1
6
10
0
3
8
Exploring neutrophils as therapeutic targets in cardiometabolic diseases https://t.co/bnlZ5X26rF
1
19
57
Glad to share this outcome🚀Multinational alliance 🇮🇹🇳🇱🇷🇺to prove potent performance of FGF5 to identify FH when 💸💸genetics is not available💥💥 The potential of A.I. is endless🤖 In search of biological relevance🧬🧫 @AL_Catapano
academic.oup.com
AbstractBackground and Aims. Identification of individuals affected by familial hypercholesterolaemia (FH) is suboptimal when genetic tests are unavailable
0
2
9
Proud of our team member @lore_ddlt for being Awarded with a scholarship at the #KSHeartFail25 on the role of mitochondrial metabolism in the interplay between heart and the liver! @KeystoneSymp! Many compliments to all the awardee!
0
4
14
Huge presentation held by @DaniloNorata at SISA italian society of Atherosclerosis💣💥. Super set of data🚀 @FraaFantini. Keep posted🤙 @LabNorata
0
4
22
Proud of @Monika_Svecla for the last published manuscript from the lab. A terrific work on the role of #ASGR1 and #glycoproteins on the development of #atherosclerosis @DaniloNorata @lore_ddlt @AndreaBaragetti @fabri_bon87
https://t.co/FpqCDYlCRD
1
3
12
Happy to share our collaborative review in @NatRevCardiol on #lysosome #immunology #metabolism & #atherosclerosis. Fun working with European colleagues @fabri_bon87 @DaniloNorata @yvancharvet. All started when met at Athero 2023 @GordonConf in Barcelona! https://t.co/axB7bhO7Gx
nature.com
Nature Reviews Cardiology - In this Review, the authors describe the bidirectional crosstalk between lysosome biology and immune cell function and polarization, focusing on immunometabolic...
2
12
54
Happy to share our latest review on lysosomal immunometabolic reprogramming in atherosclerosis just published in @NatRevCardiol 🤩 https://t.co/3k2T1gAfap
#immunometabolism
#atherosclerosis
@DaniloNorata
@LabNorata
@yvancharvet
@RazaniLab
0
3
17
CD4+ T cells exhibit distinct transcriptional phenotypes in the lymph nodes and blood following mRNA vaccination in humans
0
8
41